Kinin-Induced Anion-Dependent Secretion in Porcine Ileum: Characterization and Involvement of Opioid- and Cannabinoid-Sensitive Enteric Neural Circuits

  1. Benedict T. Green1,1,
  2. Andrew Calvin1,
  3. Scott M. O'Grady2 and
  4. David R. Brown1
  1. Departments of 1Veterinary PathoBiology, College of Veterinary Medicine, (B.T.G., A.C., D.R.B.) and 2Animal Science-Physiology, College of Agriculture, Food, and Environmental Sciences (S.M.O.), University of Minnesota, St. Paul, Minnesota
  1. Dr. David R. Brown, Department of Veterinary PathoBiology (Pharmacology Section), 1988 Fitch Ave., University of Minnesota, St. Paul, MN 55105-6010. E-mail:brown013{at}umn.edu

Abstract

The intestinal secretory actions of the proinflammatory peptide kallidin (lysyl-bradykinin) are mediated partially by enteric neurons. We hypothesized that kallidin produces neurogenic anion secretion through opioid- and cannabinoid-sensitive enteric neural pathways. Changes in short-circuit current (Isc) across sheets of porcine ileal mucosa-submucosa mounted in Ussing chambers were measured in response to kallidin (1 μM) or drugs added to the contraluminal bathing medium. Kallidin transiently increased Isc, an effect reduced after inhibition of neuronal conduction by 0.1 μM saxitoxin, cyclooxygenase inhibition by 10 μM indomethacin, or kinin B2 receptor blockade by 1 μMd-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2α,3β,7αβ)-octahydro-1H-indole-2-carbonyl-l-arginine (HOE-140). Its action was dependent upon extracellular Clor HCO Formula ions, but was resistant to 10 μM bumetanide or 0.3 mM 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid, and seemed to involve luminal alkalinization as measured by pH-stat titration. Kallidin-induced Isc elevations were sensitive to saxitoxin in tissues bathed in Cl-, but not HCO Formula -deficient media. Tissues pretreated with 0.1 μM [d-Pen2,5]-enkephalin, a selective δ-opioid agonist, displayed reduced Isc responses to kallidin; this effect was prevented by the δ-opioid antagonist naltrindole. At a contraluminal concentration of 1 μM, the cannabinoid receptor agonist (6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol (HU-210) also attenuated responses to kallidin. Proinflammatory kinins seem to stimulate neurogenic anion secretion in porcine ileum by activating enteric neural circuits expressing inhibitory opioid and possibly cannabinoid receptors.

Footnotes

  • 1 Present address: United States Department of Agriculture, Agricultural Research Service, Clay Center, NE 68933-0166.

  • This study was funded in part by National Institutes of Health Grant DA-10200. B.T.G. was a predoctoral trainee supported by National Institutes of Health Training Grant T32 DA-07239.

  • DOI: 10.1124/jpet.102.047829

  • Abbreviations:
    DPDPE
    [d-Pen2,5]-enkephalin
    CB
    cannabinoid
    HOE-140
    d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2α,3β,7αβ)-octahydro-1H-indole-2-carbonyl-l-arginine
    DALBK
    [des-Arg9,Leu8]-bradykinin
    DIDS
    4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid
    HU-210
    (6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol)
    DMSO
    dimethyl sulfoxide
    • Received December 23, 2002.
    • Accepted February 4, 2003.
« Previous | Next Article »Table of Contents